Filing Details
- Accession Number:
- 0001209191-13-044252
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-13 20:47:32
- Reporting Period:
- 2013-09-11
- Filing Date:
- 2013-09-13
- Accepted Time:
- 2013-09-13 20:47:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Biotime Inc | BTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188757 | C Stephen Farrell | 13621 Nw 12 Street, Suite 100 Sunrise FL 33323 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Vaule | Acquisiton | 2013-09-11 | 8,291 | $3.90 | 12,478 | No | 4 | P | Direct | |
| Common Shares, No Par Vaule | Acquisiton | 2013-09-12 | 2,922 | $3.86 | 15,400 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Option to Purchase Common Shares | $4.13 | 2018-06-30 | 20,000 | 20,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $4.12 | 2018-03-10 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-06-30 | 20,000 | 20,000 | Direct |
| 2018-03-10 | 20,000 | 20,000 | Direct |
Footnotes
- The price of $3.899 per share represents an average of prices ranging from $3.88 to $3.90 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- The price of $3.859 per share represents an average of prices ranging from $3.85 to $3.88 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2013 based upon continued service on the board of directors.
- Will become exercisable in four equal quarterly installments after the date of grant on May 11, 2013 based upon continued service on the board of directors.
Billionaire Hedge Funds
